Does Aspirin Like Enoxaparin Effective to Reduce Thromboembolic Disease in Patients with Total Knee Arthroplasty Surgery?
Gholamhossein Kazemian, Alireza Manafi Rasi, Mojtaba Baroutkoub, Mohammad Mahdi Sarzaeem
Journal of Pharmaceutical Research International · pp. 1–6 · Published 4 Jan 2020
10.9734/jpri/2019/v31i630370Abstract
Background: Thromboembolic disease is a common complication among patients undergoing total hip and knee arthroplasty. There are a large number of clinical trials demonstrating the efficacy of aspirin and enoxaparin in preventing pulmonary emboli and deep venous thrombosis. This study aimed to investigate the preventive role of aspirin and enoxaparin after knee arthroplasty (TKA). Methods: In this retrospective study, 160 patients undergoing knee arthroplasty at Imam Hossein Hospital, Tehran, Iran between January 2010 and February 2012 were studied. Patients were divided into treatment groups receiving enoxaparin and aspirin and were evaluated within 28 days after surgery. After examining demographic factors including age and sex, variables such as DVT, pulmonary embolus, infection, transfusion RBCs and mortality were evaluated. Results: A total thrombosis rate of 0.0125% (one deep venous thrombosis) was observed. The two groups were not significantly different in the number of patients with complications such as DVT, pulmonary embolism, infection, average number of packed RBCs, and mortality. Conclusion: We believe that course aspirin is as effective and safe as enoxaparin for thromboprophylaxis.
Cited by 0
No indexed citations yet.
Related research
- Risk Asessment and Thromboprophylaxis for Venous Thromboembolism (VTE) in the Antenatal Population in a Tertiary Health Facility in Nigeria — shares topic coverage
- Thromboprophylaxis for Intensive Care Patients — shares topic coverage
- COVID-19 Infection in Pregnancy: A Case Series from Derna, Libya — shares topic coverage
- A Comparison of Efficacy of Two Brands of Enoxaparin in COVID-19 Patients: A Pilot Study — shares topic coverage
- Successful Management of Refractory Obstetric Antiphospholipid Syndrome in a Pregnant Woman with Homozygous MTHFR Mutation: A Case Report and Literature Review — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.